Spyre Therapeutics Stock Analysis

Spyre Stock Analysis Notes

About 50.0% of the company shares are owned by institutional investors. The company had not issued any dividends in recent years. Spyre Therapeutics had 1:25 split on the 8th of September 2023. To find out more about Spyre Therapeutics contact Cameron DPHIL at 617 651 5940 or learn more at https://www.spyre.com.

Spyre Therapeutics Investment Alerts

Spyre Therapeutics Upcoming and Recent Events

Spyre Largest EPS Surprises

View All Earnings Estimates

Spyre Therapeutics Thematic Classifications

Spyre Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 990.58 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Spyre Therapeutics's market, we take the total number of its shares issued and multiply it by Spyre Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Spyre Profitablity

Management Efficiency

Spyre Therapeutics has return on total asset (ROA) of (0.4182) % which means that it has lost $0.4182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.8141) %, meaning that it created substantial loss on money invested by shareholders. Spyre Therapeutics' management efficiency ratios could be used to measure how well Spyre Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. As of May 4, 2024, Return On Tangible Assets is expected to decline to -1.04. In addition to that, Return On Capital Employed is expected to decline to -0.82. At present, Spyre Therapeutics' Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 358.6 M, whereas Non Currrent Assets Other are forecasted to decline to 8,550.

Technical Drivers

As of the 4th of May, Spyre Therapeutics has the Risk Adjusted Performance of 0.0841, semi deviation of 4.26, and Coefficient Of Variation of 838.5. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Spyre Therapeutics, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Spyre Therapeutics, which can be compared to its competition. Please validate Spyre Therapeutics standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if Spyre Therapeutics is priced more or less accurately, providing market reflects its prevalent price of 35.78 per share. Given that Spyre Therapeutics has jensen alpha of 0.5066, we advise you to double-check Spyre Therapeutics's current market performance to make sure the company can sustain itself at a future point.

Spyre Therapeutics Price Movement Analysis

Spyre Therapeutics Insider Trading Activities

Spyre Therapeutics Predictive Daily Indicators

Spyre Therapeutics Corporate Filings

Spyre Therapeutics Forecast Models

Spyre Therapeutics' time-series forecasting models are one of many Spyre Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Spyre Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Spyre Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Spyre shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Spyre Therapeutics. By using and applying Spyre Stock analysis, traders can create a robust methodology for identifying Spyre entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Spyre analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Spyre analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Spyre Therapeutics stock analysis indicators help investors evaluate how Spyre Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Spyre Therapeutics shares will generate the highest return on investment. By understating and applying Spyre Therapeutics stock analysis, traders can identify Spyre Therapeutics position entry and exit signals to maximize returns.

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Spyre Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade Spyre Stock refer to our How to Trade Spyre Stock guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

When running Spyre Therapeutics' price analysis, check to measure Spyre Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spyre Therapeutics is operating at the current time. Most of Spyre Therapeutics' value examination focuses on studying past and present price action to predict the probability of Spyre Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spyre Therapeutics' price. Additionally, you may evaluate how the addition of Spyre Therapeutics to your portfolios can decrease your overall portfolio volatility.

Is Spyre Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spyre Therapeutics. If investors know Spyre will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spyre Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Spyre Therapeutics is measured differently than its book value, which is the value of Spyre that is recorded on the company's balance sheet. Investors also form their own opinion of Spyre Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spyre Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spyre Therapeutics' market value can be influenced by many factors that don't directly affect Spyre Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Spyre Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spyre Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spyre Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.